The New York Times takes a look at some promising drugs in the pipeline and discusses the economic incentive to drug manufacturers developing effective diet pills. Names we will be hearing in the future are Arena, Orexigen and Vivus. We will be following the progress of these developmental drugs and reporting on how they advance [...]